Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Endocrine 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 171Lymphoma 93Leukemia 63Burkitt Lymphoma 57Lymphoma, Non-Hodgkin 50Lymphoma, Large B-Cell, Diffuse 44Lymphoma, Mantle-Cell 38Lymphoma, Follicular 30Recurrence 29Hodgkin Disease 29Waldenstrom Macroglobulinemia 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia, Lymphocytic, Chronic, B-Cell 26Multiple Myeloma 21Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Extranodal NK-T-Cell 16Leukemia, Biphenotypic, Acute 16Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, B-Cell 13Leukemia, Myeloid, Acute 13Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, T-Cell, Peripheral 10Neoplasms 9Lymphoma, Large-Cell, Anaplastic 9Lymphoma, T-Cell, Cutaneous 8Lymphoma, T-Cell 7Intraocular Lymphoma 6Hematologic Neoplasms 6Blast Crisis 6Sezary Syndrome 5

Interventions

Peripheral Blood Stem Cell Transplantation 17fludarabine phosphate 15Cyclophosphamide 14Cyclosporine 12Whole-Body Irradiation 11Mycophenolic Acid 11Etoposide 7Tacrolimus 5Filgrastim 5Antilymphocyte Serum 5Therapeutics 4Rituximab 4Radiotherapy 4Psychiatric Rehabilitation 4Methylprednisolone 4Melphalan 4Busulfan 4Bortezomib 4Transplantation 3Thiotepa 3Prednisone 3Methotrexate 3Epoetin Alfa 3Dasatinib 3Darbepoetin alfa 3Carboplatin 3Alemtuzumab 3thymoglobulin 2nelarabine 2liposomal amphotericin B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Large Granular Lymphocytic × Dexamethasone × Lymphoid × Clear all
NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

New York Medical College

Phase EARLY_PHASE1 Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT01088763 2014-11-05

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
129 enrolled
CNSEndocrineLymphoidOther hematologic neoplasmSarcoma

Familial ependymoma, Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Oligodendroglioma, Pituitary Neoplasms, Recurrence, Spinal Cord Neoplasms, Prolactinoma, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Rhabdoid Tumor, Optic Nerve Glioma, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡